Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-23

Clinical Trial Update: Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ReWin(d) supplementation for recovery from acute exercise-induced muscle soreness (DOMS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ReWin(d)

Snippet

Sponsor: Natural Origins | Conditions: Muscle Soreness, Delayed-onset Muscle Soreness | Phase 2 | Status: COMPLETED